- Giloy (Tinospora cordifolia) is a classical Ayurvedic herb used for fevers, digestion and as a rasayana.
- Indian hepatologists reported autoimmune-like liver injury in people taking giloy during the COVID-19 period, including a 43-patient multicentre study.
- The Ministry of AYUSH and some researchers argue misidentified species such as Tinospora crispa may explain some cases.
- Both sides agree that self-medication, adulteration and long unsupervised use are real risks.
- People with autoimmune disease, liver disease, diabetes medicines or pregnancy should not take giloy without medical advice.
In the summer of 2020, it was hard to walk through any colony in Patna without seeing someone breaking a piece of stem off the giloy vine climbing their neem tree. Kadha recipes on WhatsApp listed it first. Pharmacies sold out of giloy tablets. For many families it became a daily ritual for months.
By 2021, liver specialists in Mumbai, Hyderabad, Kochi and elsewhere were reporting patients with jaundice who had one thing in common: they had been taking giloy.
So, is giloy safe? The honest answer is: giloy (Tinospora cordifolia, called guduchi in Ayurveda) has a long classical record and is generally used safely under supervision, but peer-reviewed Indian studies have linked it to autoimmune-like liver injury in some people, especially those with underlying autoimmune tendencies. The Ministry of AYUSH has disputed these findings, pointing to species misidentification and incomplete data. Both sides agree on one practical point: giloy should not be taken for long periods without guidance, and people with liver or autoimmune disease should be especially cautious.
What giloy is, and why Ayurveda calls it amrita
Giloy is a climbing shrub with heart-shaped leaves that grows across India, often on neem or mango trees. The stem is the main part used. One of its Sanskrit names is amrita, the nectar of immortality, which tells you how highly the tradition regarded it. Folk belief holds that giloy grown on neem is the most potent, an idea from tradition rather than from controlled research.
Classical texts describe guduchi as bitter and astringent in taste, heating in potency but with a sweet post-digestive effect, and able to balance all three doshas. Its traditional uses include:
- Fevers (jvara), especially recurrent and chronic fevers
- Digestive weakness and loss of appetite
- Gout and joint conditions involving vata and rakta (blood)
- Prameha, the group of metabolic urinary disorders that includes diabetes
- Skin conditions
- Rasayana, as a rejuvenative to support strength and resistance
It also appears in well known classical formulations such as guduchyadi kashaya and amritarishta, and as guduchi satva, a starch extract.
What research says about giloy's benefits
Laboratory and animal studies suggest giloy has immunomodulatory, antioxidant, anti-inflammatory and blood sugar lowering effects. That "immunomodulatory" label is the reason it was promoted during the pandemic. Human evidence, however, is limited: mostly small clinical studies of variable quality, often using combination formulas rather than giloy alone. There is no reliable evidence that giloy prevents or treats COVID-19, dengue or any other infection by itself, and it is not a substitute for medical treatment of fever.
That does not mean the classical uses are worthless. It means we do not yet have the large, well designed trials needed to say how well it works, for whom, and at what risk.
The liver safety debate: a timeline
This is the part most giloy articles either skip or reduce to a single line. Here is what was actually published.
| When | What happened |
|---|---|
| 2020 | Giloy is widely promoted and consumed as an immunity booster during COVID-19, often in daily home kadhas and tablets for months at a time. |
| July 2021 | Hepatologists at Jaslok Hospital, Mumbai, publish a case series of six patients with acute hepatitis after giloy use, in the Journal of Clinical and Experimental Hepatology. |
| July 2021 | The Ministry of AYUSH issues a statement calling the link "misleading", arguing the study lacked dose data, did not verify the plant species and did not rule out other medicines. |
| 2022 | A multicentre study from 13 Indian centres, published in Hepatology Communications, reports 43 patients with giloy-associated liver injury. |
| 2022 to 2023 | Ayurveda researchers publish reviews arguing that adulterant species, especially Tinospora crispa, may explain the cases; hepatologists publish further case reports and commentaries. |
What the Mumbai case series found
Six patients, four women and two men, with a median age of 55, developed acute hepatitis after taking giloy for a median of about three months. Biopsies showed an autoimmune pattern of drug-induced liver injury. Four of the women turned out to have underlying silent chronic liver disease with features of autoimmunity, along with conditions such as hypothyroidism and type 2 diabetes. Five patients recovered after stopping the herb, some needing steroids; one deteriorated when steroids were tapered. The authors proposed that giloy's immune-stimulating action could trigger or unmask autoimmune liver disease.
What the 43-patient multicentre study found
Doctors from the Liver Research Club India collected cases across nine locations. More than half the patients were women. Symptoms began a median of 46 days after starting giloy. Patients presented with acute hepatitis, worsening of existing chronic liver disease (the most common picture), or acute liver failure. Causality assessment rated the liver injury as probably caused by giloy in about two thirds of cases. The study also chemically analysed retrieved samples. Its conclusion was that giloy is associated with acute hepatitis with autoimmune features and can unmask autoimmune hepatitis in people who did not know they had it.
The other side: the case for misidentification
The Ministry of AYUSH stated that giloy is safe at appropriate doses and that similar-looking plants could be responsible. A 2023 review in the Journal of Ayurveda and Integrative Medicine went further: it noted that Tinospora sinensis and Tinospora crispa are commonly traded as giloy in India, that T. crispa is known to be toxic to the liver, and that the original case series did not test the botanical identity of what patients consumed. The authors argued that authentic T. cordifolia is unlikely to cause autoimmune-like hepatitis, while acknowledging that adulteration in herbal markets is a serious problem.
My reading as an Ayurvedic doctor
I respect the classical tradition, and I also respect a hepatologist holding a biopsy report. Here is how I reconcile the two.
- The pattern is consistent. Independent teams across India saw the same autoimmune-like picture, often in middle aged women with existing autoimmune tendencies. That is a signal, not a coincidence.
- Misidentification is plausible but does not erase the signal. It may explain some cases. It is also a reason for more caution with home-plucked stems and unbranded powders, not less.
- The context was unusual. Classical Ayurveda never advised the whole population to take a strong herb every day for months without assessment. Pandemic-era self-medication broke every principle of individualised prescribing.
- "Immune boosting" is not always good. If a herb stimulates immune activity, it makes sense that it could tip someone with a latent autoimmune condition into active disease.
Who should not take giloy without medical advice
- Anyone with known or suspected liver disease, including fatty liver, or abnormal liver tests. Our article on fatty liver explains why caution with herbs matters here.
- People with autoimmune conditions: Hashimoto's thyroiditis, rheumatoid arthritis, lupus, psoriasis, type 1 diabetes and others.
- People on diabetes medicines, as giloy may lower blood sugar further. See taking Ayurvedic and allopathic medicine together.
- People on immunosuppressants, such as after transplant.
- Pregnant or breastfeeding women, as safety has not been established.
- Anyone scheduled for surgery.
- Children, unless prescribed.
Warning signs: stop and see a doctor
- Yellow eyes or skin
- Dark urine
- Persistent nausea, loss of appetite or unusual tiredness
- Itching without a rash
- Pain in the upper right abdomen
Tell the doctor you were taking giloy. The Mumbai authors made a point that applies to every clinician: in a patient with unexplained hepatitis, ask about herbal and home remedies.
If giloy is prescribed, how to make it safer
Giloy is not a forbidden herb. In appropriate patients it remains a useful part of classical practice. These steps reduce risk:
- Take it only when prescribed by a qualified practitioner who knows your history and medicines, for a defined period.
- Use a licensed product with an AYUSH licence number and batch details, not stems from an unknown vine or loose powder. See how to spot genuine Ayurvedic medicine.
- Do not combine several "immunity" products at once.
- If you are on it for more than a few weeks, ask whether a baseline and follow-up liver test makes sense.
- Stop immediately at the first warning sign.
For fever specifically, remember that in Bihar, monsoon and post-monsoon fevers include dengue, malaria and typhoid. These need testing and medical care. Giloy kadha is not a replacement for a blood test.
Seasonal colds without the giloy habit
Many people started giloy simply because they wanted to fall sick less often. Ayurveda has always placed more weight on routine than on any single herb, and these habits carry far less risk:
- Eat for the season. In the monsoon, keep meals light, warm and freshly cooked, and drink boiled water. Our monsoon health guide explains why digestion weakens in the rains.
- Use the kitchen. Ginger, black pepper, tulsi leaves and turmeric in food or a mild tea are traditional and, in food amounts, low risk.
- Sleep enough. Short sleep is one of the most reliable ways to weaken resistance.
- Move daily and get some morning sunlight.
- Keep vaccinations up to date, as advised by your doctor. Ayurveda and vaccination are not rivals.
None of these will appear in a viral forward, because none of them can be sold in a bottle. They still do more for most families than months of any immunity product.
Questions about giloy or any herb you are taking?
If you took giloy for months during the pandemic, or you are taking it now and have an autoimmune or liver condition, it is worth a careful conversation. Dr. Aditya Kunal can review what you are taking, your reports and your history, and help you decide what to continue and what to stop, in coordination with your other doctors. Consultations are available in person in Patna and online across India.
Frequently asked questions
Is giloy harmful to the liver?
Indian hepatologists have reported autoimmune-like liver injury associated with giloy, including a 43-patient multicentre study published in 2022. The Ministry of AYUSH disputes the link, citing possible species misidentification. Until this is settled, avoid long unsupervised use, especially with liver or autoimmune disease.
Can I take giloy every day for immunity?
Daily long term use without medical guidance is not advisable. Classical Ayurveda prescribes giloy for specific conditions and periods. There is no good evidence that daily giloy prevents infections in healthy people.
Who should not take giloy?
People with liver disease, autoimmune conditions, those on diabetes medicines or immunosuppressants, pregnant or breastfeeding women, children and anyone facing surgery should not take giloy without medical advice.
Is giloy good for dengue fever?
There is no reliable evidence that giloy treats dengue. Fever in the monsoon season can be dengue, malaria or typhoid and needs testing and medical care. Do not delay treatment for any home remedy.
What is the difference between Tinospora cordifolia and Tinospora crispa?
T. cordifolia is the classical guduchi. T. crispa is a related species that looks similar, is sometimes sold as giloy and is known to be toxic to the liver. This is one reason to use licensed products rather than unidentified stems or powders.
Sources and further reading
- Tinospora cordifolia (Giloy)-Induced Liver Injury During the COVID-19 Pandemic: Multicenter Nationwide Study From India (Hepatology Communications, 2022)
- Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic: A Case Series (J Clin Exp Hepatol, 2021)
- Can Guduchi (Tinospora cordifolia), a well-known ayurvedic hepato-protectant, cause liver damage? (J Ayurveda Integr Med, 2023)
- Tinospora Cordifolia (Giloy) and Autoimmune-like Liver Injury (J Clin Exp Hepatol, 2022)
- Ministry of Ayush statement: relating Giloy to liver damage completely misleading (July 2021, reported by Medical Dialogues)

